{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:41:05Z","timestamp":1788932465656,"version":"build-2803163510"},"reference-count":38,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instituto Mexicano del Seguro Social","award":["FIS\/IMSS\/PROT\/G12\/1130"],"award-info":[{"award-number":["FIS\/IMSS\/PROT\/G12\/1130"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Pentavalent antimonials are the first line for leishmaniasis treatment, although they induce many adverse side effects and treatment failure and parasite resistance have been detected. Cutaneous leishmaniasis is the main clinical manifestation of the disease in Oaxaca State, Mexico; however, its presence is under-registered, and information about the Leishmania species that circulate and cause the disease in the region is limited. In this study, the presence of Leishmania was analyzed in 24 skin smears and 2 biopsies from lesions suspicious for leishmaniasis in inhabitants of the Tehuantepec Isthmus and Papaloapan Basin regions, Oaxaca State. By ITS1-PCR, the species of clinical isolates were identified. Moreover, the susceptibility of clinical isolates to leishmanicidal drugs was assessed. Skin smears were negative for the presence of Leishmania spp.; meanwhile, parasite amastigotes were observed in tissue biopsies; however, by ITS1-PCR, 46% of the samples were determined to be positive for the parasite. Six clinical isolates were identified as L. mexicana and had lower susceptibility to Miltefosine and Amphotericin B than the L. mexicana reference strain. No leishmanicidal activity of Glucantime was detected. Further studies with increased patient sample sizes and genotypic studies will describe in detail parasite susceptibility to reference drugs in the region.<\/jats:p>","DOI":"10.3390\/microorganisms13020220","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T04:19:51Z","timestamp":1737433191000},"page":"220","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular Identification and Drug Susceptibility of Leishmania spp. Clinical Isolates Collected from Two Regions of Oaxaca, Mexico"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-8255","authenticated-orcid":false,"given":"Adriana","family":"Moreno-Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Laboratorio de Estudios Epidemiol\u00f3gicos, Cl\u00ednicos, Dise\u00f1os Experimentales e Investigaci\u00f3n, Facultad de Ciencias Qu\u00edmicas, Universidad Aut\u00f3noma \u201cBenito Ju\u00e1rez\u201d de Oaxaca, Avenida Universidad S\/N, Ex Hacienda Cinco Se\u00f1ores, Oaxaca 68120, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada Sarai Martin del","family":"Campo-Col\u00edn","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n M\u00e9dica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatr\u00eda, Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Roberto","family":"Dom\u00ednguez-D\u00edaz","sequence":"additional","affiliation":[{"name":"Centro de Patolog\u00eda Cl\u00ednica, Licenciatura en Ciencias Biom\u00e9dicas, Universidad de la Sierra Sur, UNSIS, Guillermo Rojas s\/n esq. Av. Universidad, Col. Universitaria, Miahuatl\u00e1n de Porfirio D\u00edaz, Oaxaca 70800, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Livia","family":"Posadas-Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Programa de Prevenci\u00f3n y Control de la Enfermedad de Chagas, Departamento de Prevenci\u00f3n y Control de Enfermedades Transmitidas por Vector de la Direcci\u00f3n de Prevenci\u00f3n y Promoci\u00f3n de la Salud, Servicios de Salud de Oaxaca, Oaxaca 68000, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Matadamas-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n M\u00e9dica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatr\u00eda, Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8675-5671","authenticated-orcid":false,"given":"Lili\u00e1n","family":"Y\u00e9pez-Mulia","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n M\u00e9dica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatr\u00eda, Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: A review","volume":"6","author":"Arenas","year":"2017","journal-title":"F1000Res"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/0074-02760160074","article-title":"Spatial modeling of cutaneous leishmaniasis in the Andean region of Colombia","volume":"111","author":"Ocampo","year":"2016","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0020-7519(03)00094-8","article-title":"Lutzomyia vectors for cutaneous leishmaniasis in southern Brazil: Ecological niche models, predicted geographic distributions, and climate change effects","volume":"33","author":"Peterson","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"ref_4","unstructured":"World Health Organization (2024, November 01). Leishmaniasis [Updated 1 January 2024]. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Organizaci\u00f3n Panamericana de la Salud (2022). Directrices Para el Tratamiento de las Leishmaniasis en la Regi\u00f3n de las Am\u00e9ricas, OPS. [2nd ed.].","DOI":"10.26633\/RPSP.2023.43"},{"key":"ref_6","unstructured":"Organizaci\u00f3n Panamericana de la Salud (2023). Leishmaniasis: Informe Epidemiol\u00f3gico de las Am\u00e9ricas, OPS. Available online: https:\/\/iris.paho.org\/handle\/10665.2\/51742."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ad.2021.02.008","article-title":"Cutaneous and Mucocutaneous Leishmaniasis","volume":"112","author":"Diago","year":"2021","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.actatropica.2019.03.007","article-title":"Comparison between systemic and intralesional meglumine antimoniate therapy in a primary health care unit","volume":"193","author":"Soares","year":"2019","journal-title":"Acta Trop."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Brito, N.C., Machado de Assis, T.S., Rabello, A., and Cota, G. (2019). Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007856"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Oliveira-Ribeiro, C., Pimentel, M.I.F., Oliveira, L.D.F.A., Vasconcellos, \u00c9.D.C.F.E., Concei\u00e7\u00e3o-Silva, F., Schubach, A.D.O., Fagundes, A., de Mello, C.X., Mouta-Confort, E., and Miranda, L.D.F.C. (2021). An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009734"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/524042","article-title":"Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru","volume":"46","author":"Tulliano","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40121-022-00602-2","article-title":"Treatment of cutaneous leishmaniasis and insights into species-specific responses: A narrative review","volume":"11","author":"Madusanka","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: Therapeutic response to meglumine antimoniate","volume":"65","author":"Romero","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Reveiz, L., Maia-Elkhoury, A.N., Nicholls, R.S., Romero, G.A., and Yadon, Z.E. (2013). Interventions for American cutaneous and mucocutaneous leishmaniasis: A systematic review update. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061843"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"Navin","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez, O.L., Rosales-Chilama, M., S\u00e1nchez-Hidalgo, A., G\u00f3mez, P., Rebell\u00f3n-S\u00e1nchez, D.E., Regli, I.B., D\u00edaz-Varela, M., Tacchini-Cottier, F., and Saravia, N.G. (2024). Natural resistance to meglumine antimoniate is associated with treatment failure in cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis. PLoS Negl. Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0012156"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/503371","article-title":"Resistance to antimony and treatment failure in human Leishmania (Viannia) infection","volume":"193","author":"Rojas","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4269\/ajtmh.2009.80.574","article-title":"Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil","volume":"80","author":"Unger","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Eddaikra, N., Ait-Oudhia, K., Kherrachi, I., Oury, B., Moulti-Mati, F., Benikhlef, R., Harrat, Z., and Sereno, D. (2018). Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006310"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ponte-Sucre, A., Gamarro, F., Dujardin, J.C., Barrett, M.P., L\u00f3pez-V\u00e9lez, R., Garc\u00eda-Hern\u00e1ndez, R., Pountain, A.W., Mwenechanya, R., and Papadopoulou, B. (2017). Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0006052"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/505079","article-title":"Visceral leishmaniasis, or kala azar (KA): High incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis","volume":"194","author":"Singh","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_24","first-page":"86","article-title":"Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates","volume":"46","author":"Mandal","year":"2009","journal-title":"Indian. J. Biochem. Biophys."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e24599","DOI":"10.1002\/jcla.24599","article-title":"Global distribution of treatment resistance gene markers for leishmaniasis","volume":"36","author":"Salari","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/1756-3305-7-420","article-title":"Molecular diagnosis of cutaneous leishmaniasis and identification of the causative Leishmania species in Morocco by using three PCR-based assays","volume":"7","author":"Mouttaki","year":"2014","journal-title":"Parasit. Vectors"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.diagmicrobio.2012.06.010","article-title":"Accurate and rapid species typing from cutaneous and mucocutaneous leishmaniasis lesions of the New World","volume":"74","author":"FFraga","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1590\/0074-02760140280","article-title":"Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: Systematic literature review and meta-analysis","volume":"110","author":"Gomes","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1590\/S0074-02762012000500014","article-title":"Development and validation of PCR-based assays for diagnosis of American cutaneous leishmaniasis and identification of the parasite species","volume":"107","author":"Graca","year":"2012","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/S0031182017002013","article-title":"High-throughput sequencing of kDNA amplicons for the analysis of Leishmania minicircles and identification of Neotropical species","volume":"145","author":"Kocher","year":"2018","journal-title":"Parasitology"},{"key":"ref_31","first-page":"331","article-title":"The accuracy of diagnosis and genotyping of Leishmania species based on spliced leader mini-exon gene by nuclear magnetic resonance and sequencing assays","volume":"18","author":"Khorram","year":"2023","journal-title":"Iran. J. Parasitol."},{"key":"ref_32","first-page":"607287","article-title":"ITS1 PCR-RFLP Diagnosis and characterization of Leishmania in clinical samples and strains from cases of human cutaneous leishmaniasis in States of the Mexican Southeast","volume":"2014","author":"Nasereddin","year":"2014","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0035-9203(02)90056-8","article-title":"Molecular epidemiology and diagnosis of Leishmania: What have we learnt from genome structure, dynamics and function?","volume":"96","author":"Dujardin","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4269\/ajtmh.2011.10-0452","article-title":"Current knowledge of Leishmania vectors in Mexico: How geographic distributions of species relate to transmission areas","volume":"85","author":"Peterson","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_35","unstructured":"(2018, January 01). Control of the Leishmaniases: Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010. Available online: https:\/\/iris.who.int\/handle\/10665\/44412."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bilbao-Ramos, P., Serrano, D.R., Ruiz Salda\u00f1a, H.K., Torrado, J.J., Bol\u00e1s-Fern\u00e1ndez, F., and Dea-Ayuela, M.A. (2020). Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis. Molecules, 25.","DOI":"10.3390\/molecules25061394"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0035-9203(02)90044-1","article-title":"Mechanisms of pathogenesis: Differences amongst Leishmania species","volume":"96","author":"Colmenares","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1007\/s00436-021-07166-z","article-title":"Molecular characterization of Leishmania species from stray dogs and human patients in Saudi Arabia","volume":"120","author":"Alanazi","year":"2021","journal-title":"Parasitol. Res."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/2\/220\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:32:37Z","timestamp":1759919557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/2\/220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["microorganisms13020220"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms13020220","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]}}}